# Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma

> **NCT07538856** · — · NOT_YET_RECRUITING · sponsor: **Beijing GoBroad Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Gastric
- Gastric / Gastroesophageal Junction Adenocarcinoma

## Interventions

- **DRUG:** Initial Dose (Dose Group 1)
- **DRUG:** Dose Group 2
- **DRUG:** Dose Group 3
- **DRUG:** Dose Group 4
- **DRUG:** Dose Group 5
- **DRUG:** Dose Group 6

## Key facts

- **NCT ID:** NCT07538856
- **Lead sponsor:** Beijing GoBroad Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-04
- **Final completion:** 2028-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07538856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07538856, "Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07538856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*